pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
Rejuvenated Stem Cell Therapy
Bone Marrow Transplant Rejection
Hexem Bio Inc
0 catalysts
Marketed
Relexxii
Relexxii (methylphenidate hydrochloride)
Attention Deficit Hyperactivity Disorder (ADHD)
Vertical Pharmaceuticals LLC
0 catalysts
Marketed
Relpax
Relpax (eletriptan hydrobromide)
Migraine
$VTRSViatris Inc
0 catalysts
Marketed
← prev
page 151 of 271
next →
131
Pain89
Neurology1
Remeron
Remeron (mirtazapine)
Major Depressive Disorder
Organon USA LLC
0 catalysts
Marketed
Remodulin
Remodulin (treprostinil)
Pulmonary Arterial Hypertension
$UTHRUNITED THERAPEUTICS Corp
0 catalysts
Phase 2
Remygen
Type 1 Diabetes (Juvenile Diabetes)
Diamyd Medical AB
0 catalysts
Phase 3
Restem-L
Dermatomyositis
RESTEM Group Inc
0 catalysts
Marketed
Rethymic
DiGeorge Syndrome
Sumitomo Pharma America Inc
0 catalysts
Marketed
Retisert
Retisert (fluocinolone acetonide)
Non-infectious Uveitis
$BLCOBausch & Lomb Corp
0 catalysts
Phase 2
ReversPAH
Pulmonary Arterial Hypertension
Artin Bioscience Inc
0 catalysts
Marketed
Reyataz
Reyataz (atazanavir sulfate)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Bristol-Myers Squibb Co
0 catalysts
Marketed
Rezipres
Rezipres (ephedrine hydrochloride)
Hypotension
Dr. Reddy's Laboratories Ltd
0 catalysts
Preclinical
RgnA-09M
Osteoarthritis
Regenosine Inc
0 catalysts
Phase 1
RiVax
Poisoning
$SNGXSOLIGENIX, INC.
0 catalysts
Marketed
Rimso
Rimso (dimethyl sulfoxide)
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)
Mylan Pharmaceuticals Inc
0 catalysts
Phase 1
RioCard-001
Myocardial Infarction
Rion Inc
0 catalysts
Phase 2
RioDerm-001
Diabetic Foot Ulcers
Intent Biologics Inc
0 catalysts
Phase 1
RioMSK-001
Osteoarthritis
Rion Inc
0 catalysts
Marketed
Ritonavir Cipla
Ritonavir (ritonavir)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Cipla USA Inc
0 catalysts
Marketed
Rowasa
Rowasa (mesalamine)
Proctitis
Mylan Specialty LP
0 catalysts
Marketed
Rozex
Metrogel (metronidazole)
Rosacea
Galderma Laboratories LP
0 catalysts
Phase 2
Ruvembri
Sarcopenia
Biophytis SA
0 catalysts
Marketed
Rybelsus
Rybelsus (semaglutide)
Cardiovascular Risk Factors
Novo Nordisk Inc
0 catalysts
Marketed
Rylaze
Rylaze (asparaginase erwinia chrysanthemi-rywn)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$JAZZJazz Pharmaceuticals plc
0 catalysts
Marketed
Rytary
Rytary ((carbidopa + levodopa))
Parkinson's Disease
$AMRXAmneal Pharmaceuticals, Inc.
0 catalysts
Phase 2
S-309309
Obesity
$SGIOFSHIONOGI & CO LTD
0 catalysts
Phase 2
S-337395
Respiratory Syncytial Virus (RSV) Infections
$SGIOFSHIONOGI & CO LTD
0 catalysts
Phase 2
S-4V2
Bacillary Dysentery (Shigellosis)
$VALNValneva SE
0 catalysts
Phase 2
S-531011
Adenocarcinoma Of The Gastroesophageal Junction
$SGIOFSHIONOGI & CO LTD
0 catalysts
Phase 1
S-740792
Gait Abnormality (Walking Difficulty)
$SGIOFSHIONOGI & CO LTD
0 catalysts